Copyright © 2026 A&T Respiratory Lectures All Rights Reserved
By Terrence Shenfield MS, RRT-ACCS, RPFT, NPS, AE-C
Respiratory syncytial virus (RSV) infection is widely recognized as a major cause of morbidity and mortality, particularly in newborns and young children. However, its impact in adults, especially older populations, is often underestimated. For respiratory therapists, understanding the symptoms, risks, and current treatment and prevention strategies for RSV is critical to providing quality patient care.
This guide will provide respiratory therapists with valuable insights into RSV infection in adults, the challenges it presents, and actionable respiratory care best practices.
RSV is a pulmonary infectious disease caused by a highly contagious virus that affects the respiratory tract. It is most commonly associated with severe infections in infants and young children but also has significant implications for adults, particularly senior populations with underlying health conditions.
Among adults, RSV infections are often underdiagnosed, with many attributing symptoms to other common respiratory illnesses like influenza or the common cold. This lack of recognition, combined with aging populations and increasing comorbidities, has contributed to a growing need for targeted RSV prevention and treatment measures.
RSV infections in adults present a bigger public health challenge than many realize. While it may cause mild symptoms in healthy adults, it can lead to severe complications in high-risk groups, including older individuals (particularly those aged 70 and above) and those with chronic pulmonary or cardiovascular illnesses.
Aging Populations: The aging process naturally weakens the immune system, a phenomenon known as immunosenescence. This makes older adults more vulnerable, requiring vigilant respiratory infection control CEUs for healthcare professionals managing these cases.
Comorbidities: Pre-existing conditions such as COPD, asthma, heart disease, or diabetes exacerbate RSV complications, making them life-threatening.
Wide Range of Clinical Presentations: RSV symptoms can range from mild cold-like symptoms to acute pneumonia and life-threatening respiratory distress. Symptoms often mimic other illnesses, complicating diagnosis and delaying treatment.
Potential Epidemics: Rising healthcare demands in high-income countries mean more frequent and large-scale outbreaks as immunosenescence and chronic comorbidities become more prevalent.
For respiratory therapists, this underscores the importance of recognizing RSV symptoms and implementing respiratory care best practices for RSV to mitigate complications and ensure improved patient outcomes.
RSV in adults may manifest through a variety of symptoms, including mild respiratory infections or severe respiratory failure.
Persistent cough
Nasal congestion or runny nose
Fatigue and muscle aches
Fever
Acute pneumonia
Bronchiolitis
Respiratory distress
Exacerbation of chronic respiratory conditions such as asthma or COPD
The severity of symptoms often dictates the level of medical intervention required, from supportive care (hydration and oxygen) to intensive treatment in complicated cases.
For most cases, RSV care is supportive. However, decisions should always consider the severity of the infection and individual patient factors.
Hydration & Antipyretics: These steps help manage fever and prevent dehydration in mild cases.
Oxygen Support: Administer oxygen to patients displaying difficulty breathing or low oxygen saturation levels.
Monitoring High-Risk Patients: Watch older adults or immunocompromised individuals closely, as RSV may quickly become severe.
Access additional patient safety resources here.
Respiratory therapists play a critical role in controlling the spread of RSV, both within healthcare facilities and the wider community.
Effective infection control measures include:
Washing hands thoroughly between patients.
Wearing protective equipment such as gloves and masks.
Properly disinfecting equipment and surfaces.
These measures align with respiratory infection control CEUs and ensure a safe environment for both patients and staff.
One of the greatest challenges with RSV is the lack of targeted antiviral treatments, especially for adults. Current therapies focus on managing symptoms, but progress is being made in preventive interventions such as vaccines.
Recent developments in vaccination technologies have introduced preventative options for high-risk adults, such as Arexvy (GSK) and Abrysvo (Pfizer). These vaccines have shown encouraging effectiveness in reducing severe RSV outcomes and offer hope for controlling future epidemics.
Respiratory therapists should stay informed about these breakthroughs to offer patients the most up-to-date advice.
Learn more about RSV treatments in this video.
Education is key to better managing RSV cases and ensuring optimal patient care. Ongoing professional development and respiratory infection control CEUs help keep respiratory therapists equipped with the latest tools and knowledge in combating pulmonary infectious diseases like RSV.
New advancements in RSV prevention.
Techniques for reducing hospitalization through effective patient monitoring.
Updates on emerging antiviral treatments for respiratory infections.
Start exploring CEU opportunities for patient safety here.
Respiratory therapists are uniquely positioned to manage RSV effectively by emphasizing prevention, detection, and treatment. Some key practices to incorporate include:
Patient Awareness: Educate at-risk individuals, such as older adults and those with chronic conditions, about RSV risks and symptoms.
Early Diagnosis: Utilize diagnostic tools to differentiate RSV from influenza or the common cold, ensuring timely and appropriate intervention.
Team Collaboration: Work closely with other healthcare professionals to ensure comprehensive treatment plans are in place.
Through these measures, respiratory therapists not only improve individual patient outcomes but also contribute to reducing RSV-related healthcare burdens.
Given the potential for large-scale outbreaks in older populations, public awareness and vaccination campaigns are essential in high-income countries.
Educational initiatives targeting at-risk groups.
Community-based vaccination drives employing vaccines like Arexvy and Abrysvo.
Strengthening infection control practices in healthcare settings.
RSV presents as a reminder of why respiratory infection control CEUs and professional training are vital for healthcare professionals. Adopting respiratory care best practices for RSV, including rigorous infection control protocols, effective patient monitoring, and proactive engagement with high-risk groups, will be key to managing RSV as public health needs evolve.
For respiratory therapists looking to stay ahead of the curve, consider accessing the latest guidelines, CEUs, and patient safety information through A&T Respiratory Lectures.
RSV infection in adults is an urgent and growing challenge, with significant consequences for patients and healthcare systems alike. While current care largely focuses on supportive measures, advancements in vaccines and antiviral therapies are paving the way for improved outcomes.
For respiratory therapists, this is a call to action to remain informed, sharpen infection control protocols, and continue expanding their expertise through respiratory infection control CEUs. Together, these efforts can directly impact patient safety and strengthen outcomes in RSV care.
Are you ready to take your knowledge to the next level?
Head over to A&T Respiratory Lectures to explore resources, CEUs,
Respiratory care changes fast. At A&T Respiratory Lectures, we want to help you stay ahead.
Our articles are great for everyone. Experienced therapists use them to improve patient care. Newcomers use them to grow their careers. We provide the tools you need to succeed.